title: Evaluation of a Large Renal Mass Using 99mTc-MIBI SPECT/CT in a Patient With Chronic Kidney Disease.
abstract: The differentiation of benign and indolent renal masses from aggressive tumor histologies cannot be reliably performed by CT or MRI. Additionally, renal mass biopsy risks complications and has a nondiagnostic rate of 10% to 20%. Tc-MIBI SPECT/CT has been shown to allow for the accurate differentiation of benign renal oncocytomas and hybrid oncocytic/chormophobe tumors from other more aggressive renal tumor types. We present the case of an 84-year-old man with chronic kidney disease and an 11.2-cm renal mass. Results of his Tc-MIBI SPECT/CT allowed avoidance of a radical nephrectomy.
authors.affiliation: From the *The Russell H. Morgan Department of Radiology and Radiological Science, and †The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: Steven P
authors.initials: SP
authors.lastname: Rowe
authors.forename: Michael A
authors.initials: MA
authors.lastname: Gorin
authors.forename: Mehrbod S
authors.initials: MS
authors.lastname: Javadi
authors.forename: Mohamad E
authors.initials: ME
authors.lastname: Allaf
mesh_terms: D000369:Aged, 80 and over; D003937:Diagnosis, Differential; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D019275:Radiopharmaceuticals; D051436:Renal Insufficiency, Chronic / Q000000981:diagnostic imaging*; D000072098:Single Photon Emission Computed Tomography Computed Tomography; D017256:Technetium Tc 99m Sestamibi
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi